Posted by Michael Wonder on 26 May 2022
COVID-19 vaccine weekly safety report (26 May 2022)
26 May 2022 - To 22 May 2022, the TGA has received 555 reports which have been assessed as likely to be myocarditis from about 40.5 million doses of Comirnaty (Pfizer) and 92 reports which have been assessed as likely to be myocarditis from about 4.4 million doses of Spikevax (Moderna).
The TGA has received 2 reports which have been assessed as likely to be myocarditis from about 140,000 doses of Nuvaxovid.
